MedSina
Health library › Evidence-based

Effective Strategies for Hypertension Treatment and Control

November 5, 2026·5 min read ·MedSina Evidence · PubMed

Despite significant advances in medicine, achieving optimal blood pressure control remains a global challenge, requiring comprehensive strategies to reduce cardiovascular risks.

Effective Strategies for Hypertension Treatment and Control

Hypertension, commonly known as high blood pressure, is a widespread health concern affecting over 1 billion people worldwide [1]. It stands as the leading preventable risk factor for cardiovascular disease (CVD) and is responsible for more than 10 million preventable deaths globally each year [1]. The World Health Organization estimates that the number of individuals living with hypertension nearly doubled between 1990 and 2019, rising from 650 million to 1.28 billion [8]. Elevated blood pressure significantly increases the risks of serious health issues such as stroke, coronary artery disease, heart failure, and chronic kidney disease [8].

The Global Challenge of Uncontrolled Blood Pressure

Despite the availability of diagnostic tools and effective treatments, achieving controlled blood pressure remains a significant challenge. Globally, only about one in seven individuals diagnosed with hypertension manage to keep their blood pressure within healthy targets [1]. This issue persists even with ongoing medical advancements [2].

Various factors contribute to this widespread lack of control. For instance, young adults often exhibit poorer hypertension treatment and control compared to older adults [3]. In young men, factors such as age, marital status, family history of hypertension, treatment for hyperlipidemia, and abdominal obesity have been identified as influencing blood pressure control [3].

Studies highlight gaps in care. In Canada, a retrospective study of adults with diabetes and hypertension found that 69% had blood pressure readings of 130/80 mmHg or higher, with 46% having readings of 140/90 mmHg or higher [4]. A significant finding was that most individuals were receiving monotherapy (60%), and only 23% of those with uncontrolled blood pressure received guideline-concordant care, such as repeat blood pressure assessment and drug intensification within six weeks [4]. Similarly, data from the United States in 2014 showed varied blood pressure control rates, with treatment predominantly involving older medications [6]. In Ethiopia, only 37% of patients achieved controlled blood pressure, and treatment was intensified for only 23% of those with uncontrolled readings [7].

Evidence-Based Strategies for Better Control

To improve hypertension control, particularly in low- and middle-income countries, health systems-strengthening approaches are crucial. The Standardized Hypertension Treatment and Prevention Project (SHTPP) advocates for standardized management using evidence-based interventions [1]. Key strategies include:

These approaches, combined with contemporary evidence-based guidelines, offer new hope for optimizing blood pressure control and reducing the incidence of cardiovascular disease [2].

Addressing Complex Cases: Orthostatic and Resistant Hypertension

Managing hypertension can be particularly complex when other conditions are present. For example, hypertension and orthostatic hypotension (OH) often coexist [5]. OH is characterized by a drop in systolic blood pressure of 20 mmHg or more, or diastolic blood pressure of 10 mmHg or more, when a person stands up from a seated or supine position [5]. In such cases, treatment strategies must be carefully tailored to balance the risks associated with both high blood pressure (like heart disease and stroke) and low blood pressure (such as falls and fainting) [5]. The specific cause of OH also influences the treatment approach [5].

Another challenging condition is resistant hypertension, defined as an office blood pressure of 140/90 mmHg or higher despite treatment with three different classes of antihypertensive agents (including a diuretic) at maximally tolerated doses, or the need for four or more agents regardless of the blood pressure level [8]. These cases often require specialized management strategies.

Innovative Treatments on the Horizon

Beyond conventional medications, innovative device-based therapies are being developed, especially for patients with resistant hypertension [8]. These treatments primarily target the autonomic nervous system, which plays a key role in blood pressure regulation [8]. Examples of these emerging interventions include:

These innovative approaches aim to provide additional options for optimizing blood pressure control and further reducing the risk of cardiovascular disease [2, 8].

The Path to Better Blood Pressure Control

Achieving widespread and sustained blood pressure control requires a coordinated effort across healthcare systems, providers, and patients. Studies indicate that longer treatment duration is positively associated with better blood pressure control [7]. Continuous implementation of evidence-based guidelines, improved access to affordable medications, and patient engagement are crucial steps in tackling this global health challenge and improving outcomes for millions worldwide [1, 2].

Sources

hypertensionblood pressure controlcardiovascular diseasetreatment strategiespublic health

This article summarises published research for a general audience. It is not medical advice — talk to a qualified clinician about your own situation. Need help finding one? Browse doctors.